The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
Amanda M EudyBryce B ReeveTheresa ColesLi LinJennifer L RogersDavid S PisetskyLisa G Criscione-SchreiberJayanth DossRebecca SadunKai SunMegan Eb ClowsePublished in: Lupus (2022)
Our findings indicate Type 2 SLE activity can be identified by patient-reported data. The use of PROs was not as accurate at predicting Type 1 activity. These findings highlight the challenges of using PROs to categorize and classify SLE symptoms since some manifestations of Type 1 activity (e.g., nephritis) may be essentially clinically silent while other Type 1 manifestations may cause severe symptoms.